Dr. Michael Scordo is an Associate Attending on the Adult Bone Marrow Transplant and Cellular Therapy Services at Memorial Sloan Kettering Cancer Center and an academic clinical investigator specializing in hematopoietic cell transplantation and cellular immunotherapies for hematologic malignancies. His clinical-translational research focuses on improving the safety and efficacy of these therapies through precision conditioning strategies, personalized drug dosing, and the development of next-generation cellular therapies. He also leads research efforts aimed at optimizing treatment approaches for patients with central nervous system lymphoma. In addition to his research program, Dr. Scordo holds institutional leadership roles, directs clinical partnerships, and mentors fellows and junior faculty.

Areas of Special Interest:

• Hematopoietic cell transplantation and cellular therapies 
• Precision conditioning and model-informed drug dosing 
• Toxicity reduction 
• Post-transplant relapse prevention 
• Next-generation cellular immunotherapies
• Central nervous system lymphoma